Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price reached a new 52-week high on Thursday . The stock traded as high as $175.5590 and last traded at $175.5590, with a volume of 19 shares. The stock had previously closed at $170.00.
Merck KGaA Trading Up 5.8%
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a fifty day moving average price of $149.16 and a 200 day moving average price of $144.55. The company has a market cap of $22.69 billion, a price-to-earnings ratio of 26.80 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 3 Dividend ETFs Built for Stability in a Volatile Market
- General Mills Is a 5-Star Turnaround Play for Buy and Hold Investors
- Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI
- SMRs Spark a Chain Reaction for Nano Nuclear
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
